Valocor Therapeutics
Vancouver
About Valocor Therapeutics
Valocor Therapeutics, Inc., a clinical stage biotech company, develops new therapies to treat dermatological conditions with unmet medical needs. Its products include Lemuteporfin, a potent and selective topical photodynamic therapy approach to sebaceous gland targeting for severe acne; VAL-001, a topical sebum inhibitor targeting acne and sebaceous gland hyperactivity; VAL-002, a small-molecule kinase-inhibitor for topical treatment of chronic inflammatory skin diseases; and VAL-003, a Kinase inhibitor with dual melanin-stimulating and immune-modulating activities. Valocor Therapeutics, Inc. was founded in 2008 and is based in Vancouver, Canada.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Series Unknown (May 2010)
- Website: valocor.com
- Phone: 604-295-0729
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/valocor-therapeutics-2256900 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.